Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




African American Women Less Likely to Undergo BRCA1/2 Genetic Testing
Link ID 2506
Title African American Women Less Likely to Undergo BRCA1/2 Genetic Testing
Url http://www.medscape.com/viewarticle/568927?src=rss
Description In general, African American women are less likely than white women to pursue genetic testing for BRCA1/2, researchers report. However, African American women with a recent diagnosis of breast cancer are much more likely to do so, according to the article in the January 1st issue of the Journal of Clinical Oncology. Reuters Health Information
Category Articles > Hematology-Oncology
Keywords
Date Jan 18, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Biological Markers in the Diagnosis of Recurrent Bladder Cancer: An Overview
  The authors provide an overview on the biological markers that can play a role in early bladder cancer detection and can perhaps subsequently reduce the need for frequent cystoscopies.
Expert Review of Molecular Diagnostics
Category:   Articles > Hematology-Oncology


2. Participants in Phase 1 Oncology Trials Not Vulnerable
  Because phase I oncology trials offer relatively little clinical benefit but do carry with them the risk for serious harm, they have been cited as paradigmatic examples of research that exploits vulnerable people. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Height May Be a Risk Factor for Prostate Cancer
  Taller men and those with longer leg-to-trunk height ratios may be at slightly increased risk for prostate cancer overall, and for high-grade cancer in particular, suggest results of a case-control study and meta-analysis. But the finding, while interesting, does not suggest a need for changes in screening or treatment, and should not be of concern to basketball players or other tall men. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. FDA Approves Test to Help Diagnose Unknown Primary Tumor Diagnoses
  Pathwork Tissue of Origin Test is a gene expression test using microarray technology to help diagnose the primary site of tumors of unclear origin. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Vitamin D May Not Decrease Risk for Prostate Cancer
  In a large prospective study, higher circulating serum concentrations of 25-hydroxyvitamin D were associated with an increased risk for aggressive prostate cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS